Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0790
+0.0020 (2.60%)
Oct 22, 2026, 4:10 PM AEDT
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 61.23 million as of October 22, 2026. It is the 31,403rd most valuable company in the world and the 728th biggest in Australia. Its market cap has decreased by 15.15% in one year.
Market Cap
61.23M
Enterprise Value
51.83M
Revenue
17.59M
Global Rank
Country Rank
#728 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 61.23M, an increase of 1,363.78%. That is a compound annual growth rate of 11.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 61.23M | 34.45% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 107.02M |
| Nyrada | 105.23M |
| Island Pharmaceuticals | 97.71M |
| LTR Pharma | 85.67M |
| Prescient Therapeutics | 66.34M |
| Alterity Therapeutics | 61.86M |
| Arovella Therapeutics | 60.44M |
| Avecho Biotechnology | 54.09M |